-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Low_Income
February 19, 2021 - Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 0.3
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Residence_Location/Noncore
A1c measurements in the calendar year
77.6
79.5
Achieved within: 2.4%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Residence_Location/Micropolitan
A1c measurements in the calendar year
78.5
79.5
Achieved within: 1.2%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Income/Poor
Measure Average Annual Percent Change
Children ages 2-19 with obesity 1.6
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Income/High_Income
who received at least two hemoglobin A1c measurements in the calendar year -0.0
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Income/Low_Income
Children ages 19-35 months who received 3 or more doses of hepatitis B vaccine 0.3
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Income/Middle_Income
who received at least two hemoglobin A1c measurements in the calendar year 0.6
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Poor
Measure Average Annual Percent Change
Children ages 2-19 with obesity 1.6
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Middle_Income
who received at least two hemoglobin A1c measurements in the calendar year 0.6
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Residents_of_Rural_Areas
February 17, 2021 - source of ongoing care -3.0
People under age 65 with health insurance -3.0
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Poor
doses of measles-mumps-rubella vaccine
90.3
96.4
Achieved within: 6.3%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Middle_Income
pertussis (Tdap) since the age of ten years
88.5
95.2
Achieved within: 7.1%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/Low_Income
received 3 or more doses of polio vaccine
92.7
97.3
Achieved within: 4.7%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Income/High_Income
ever received pneumococcal vaccination
72.0
78.7
Achieved within: 8.5%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Middle_Income
since the age of ten years
Middle
88.5
95.2
Achieved within: 7.1%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Residents_of_Rural_Areas
February 19, 2021 - measurement in the last 5 years
Micropolitan (nonmetro)
81.3
82.3
1.2%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/High_Income
February 19, 2021 - received pneumococcal vaccination
High
72.0
78.7
Achieved within: 8.5%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Low_Income
February 19, 2021 - doses of polio vaccine
Near poor/low
92.7
97.3
Achieved within: 4.7%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Poor
measles-mumps-rubella vaccine
Negative/poor
90.3
96.4
Achieved within: 6.3%
Women with clinical Stage
-
nhqrnet.ahrq.gov/inhqrdr/xls/Benchmarking_UseGuide.pdf
September 01, 2013 - Hospital OQR)
• Physician Quality Reporting System (PQRS)
• Nursing Home
• Home Health
• End-Stage